Olema Pharmaceuticals, Inc. (OLMA) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -1001.3%, revenue growth 11.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $16.22M |
| Revenue (TTM) | $0.0B |
| Net Margin | -1001.3% |
| Return on Equity | -47.5% |
| Operating Margin (TTM) | -1305.3% |
| Current Ratio | 8.86 |
| Revenue Growth (YoY) | 11.5% |
| EPS Growth (YoY) | 19.6% |
| FCF Growth (YoY) | 54.3% |
| Price / Book | 1.83 |
| Price / Sales | 46.48 |
| Altman Z-Score | 6.98 (safe) |
| Industry P/E (Pharmaceutical Products) | 15.1 |
| Sector P/E (Healthcare) | 19.4 |
OLMA overview · OLMA earnings · OLMA KPIs · OLMA documents · OLMA ownership · OLMA peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.